Results 21 to 30 of about 207,971 (196)

Bismuth-based quadruple therapy following H. Pylori eradication failures: A multicenter study in clinical practice [PDF]

, 2015
Background & Aims: Helicobacter pylori (H. pylori) eradication in patients who failed one or more therapeutic attempts remains challenging. This study aimed to assess the efficacy of three-in-one capsules bismuth-based quadruple therapy (Pylera®) in ...
Zullo, Angelo, De Francesco, Vincenzo, Bellesia, Annamaria, Vassallo, Roberto, D’angelo, Audenzio, Scaccianoce, Giuseppe, Sacco, Rodolfo, Bresci, Giampaolo, Eramo, Annarita, Tanzilli, Anna, Ridola, Lorenzo, Alvaro, Domenico, Londoni, Claudio, Brambilla, Gianfranco, Manta, Raffaele, Di Ciaula, Agostino, Portincasa, Piero   +16 more
core   +8 more sources

A novel taxon selection method, aimed at minimizing recombination, clarifies the discovery of a new sub‐population of Helicobacter pylori from Australia

Evolutionary Applications, 2020
We present a novel method for taxon selection, the aim being to minimize problems arising from highly recombinant species such as Helicobacter pylori.
Binit Lamichhane, Michael J. Wise, Eng Guan Chua, Barry J. Marshall, Chin Yen Tay   +4 more
doaj   +1 more source

A study on the diagnosis of the Helicobacter pylori coccoid form with artificial intelligence technology

Frontiers in Microbiology, 2022
BackgroundHelicobacter pylori (H. pylori) is an important pathogenic microorganism that causes gastric cancer, peptic ulcers and dyspepsia, and infects more than half of the world’s population. Eradicating H. pylori is the most effective means to prevent
Zishao Zhong, Zishao Zhong, Zishao Zhong, Zishao Zhong, Xin Wang, Xin Wang, Xin Wang, Jianmin Li, Beiping Zhang, Beiping Zhang, Lijuan Yan, Shuchang Xu, Shuchang Xu, Guangxia Chen, Hengjun Gao, Hengjun Gao, Hengjun Gao, Hengjun Gao   +17 more
doaj   +1 more source

Effects of cholesterol-lowering probiotics on non-alcoholic fatty liver disease in FXR gene knockout mice

Frontiers in Nutrition, 2023
Background/aimsSome studies showed that probiotics could improve the composition and structure of gut microbiota. Changes in the gut microbiota may alter bile acid (BAs) composition and kinetics, improving non-alcoholic fatty liver disease (NAFLD ...
Minghua Yang, Minghua Yang, Haoyang Wang, Haoyang Wang, Ihtisham Bukhari, Ye Zhao, Ye Zhao, Huang Huang, Yong Yu, Xiangdong Sun, Yang Mi, Yang Mi, Lu Mei, Pengyuan Zheng, Pengyuan Zheng   +14 more
doaj   +1 more source

Friend and foe: factors influencing the movement of the bacterium Helicobacter pylori along the parasitism-mutualism continuum. [PDF]

, 2014
Understanding the transition of bacterial species from commensal to pathogen, or vice versa, is a key application of evolutionary theory to preventative medicine.
Koskella, Britt, Lin, Derek
core   +1 more source

Clinical implications of lncRNA LINC-PINT in cancer

Frontiers in Molecular Biosciences, 2023
Long noncoding RNAs (lncRNAs) possess the potential for therapeutic targeting to treat many disorders, including cancers. Several RNA-based therapeutics (ASOs and small interfering RNAs) have gained FDA approval over the past decade.
Ihtisham Bukhari, Muhammad Riaz Khan, Fazhan Li, Bartlomiej Swiatczak, Rick Francis Thorne, Pengyuan Zheng, Yang Mi   +6 more
doaj   +1 more source

Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease : systematic review. [PDF]

, 2003
Objectives: To ascertain the prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease and its association with the disease.
Childs, S., Hungin, A. P. S., Raghunath, A., Wooff, D.   +3 more
core   +2 more sources

Multiple pathways of plasmid DNA transfer in Helicobacter pylori [PDF]

, 2012
Many Helicobacter pylori (Hp) strains carry cryptic plasmids of different size and gene content, the function of which is not well understood. A subgroup of these plasmids (e.g.
Benghezal, Mohammed, Fischer, Wolfgang, Haas, Rainer, Holsten, Lea, Rohrer, Stefanie, Weiss, Evelyn   +5 more
core   +3 more sources

Comparison of omeprazole, metronidazole and clarithromycin with omeprazole/amoxicillin dual-therapy for the cure of Helicobacter pylori infection [PDF]

, 1998
In this randomized, multicenter trial, we evaluated the effectiveness and side effect profile of a modified omeprazole-based triple therapy to cure Helicobacter pylori infection.
Bayerdörffer, Ekkehard, Bolle, Karl-Heinz, Höchter, Wilhelm, Klann, Hermann, Krämer, Walter, Lehn, Norbert, Meining, Alexander, Miehlke, Stephan, Simon, Thomas, Sommer, Albrecht, Stolte, Manfred, Weingart, Josef   +11 more
core   +1 more source

Effect of native gastric mucus on in vivo hybridization therapies directed at Helicobacter pylori [PDF]

, 2015
Helicobacter pylori infects more than 50% of the worldwide population. It is mostly found deep in the gastric mucus lining of the stomach, being a major cause of peptic ulcers and gastric adenocarcinoma. To face the increasing resistance of H.
Azevedo, Nuno F, Braeckmans, Kevin, Dakwar, George, De Smedt, Stefaan, Figueiredo, Céu, Fontenete, Silvia, Forier, Katrien, Guimarães, Nuno, Leite, Marina, Remaut, Katrien, Santos, Rita, Stremersch, Stephan, Wengel, Jesper, Xiong, Ranhua   +13 more
core   +6 more sources